PI3King the Environment for Growth: PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth. Editorial Article uri icon

Overview

abstract

  • PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating mutations in PIK3CA alter the use of known exons and splice junctions, leading to changes in gene expression and transcription factor activity that promote an oncogenic phenotype. Their work reveals a novel mechanism underlying the functional impact of PI3K signal activation in the context of breast cancer, where PIK3CA mutations are common and PI3K inhibitors are part of the standard of care. Their studies uncover a feedforward mechanism by which PI3K signaling enables a shift in the spectrum of translated splice variants as another method through which the PI3K pathway has evolved to regulate its own activity, thereby modifying the cellular response to upstream activation based on the signaling that has come before. These findings have profound implications for understanding the evolution of the PI3K pathway and the rewiring of cells in response to prolonged or repeated signal activation. See related article by Ladewig et al., p. 2269.

publication date

  • June 15, 2022

Research

keywords

  • Breast Neoplasms
  • Phosphatidylinositol 3-Kinases

Identity

PubMed Central ID

  • PMC10309115

Scopus Document Identifier

  • 85132082635

Digital Object Identifier (DOI)

  • 10.1158/0008-5472.CAN-22-1466

PubMed ID

  • 35702891

Additional Document Info

volume

  • 82

issue

  • 12